Development of transcriptomic tools for predicting the response to individual drug of the mFOLFIRINOX regimen in patients with metastatic pancreatic cancer

Overview of attention for article published in Frontiers in oncology, September 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter: 5 X users

So far, Altmetric has seen 7 X posts from 5 X users, with an upper bound of 12,717 followers.

RT @NelsonDusetti: Excited to announce the expansion of the Pancreas View transcriptomic signatures to predict treatment response in metast…

11 Sep 2024

Reply Repost Favourite

RT @NelsonDusetti: Excited to announce the expansion of the Pancreas View transcriptomic signatures to predict treatment response in metast…

11 Sep 2024

Reply Repost Favourite

RT @NelsonDusetti: Excited to announce the expansion of the Pancreas View transcriptomic signatures to predict treatment response in metast…

11 Sep 2024

Reply Repost Favourite

Thrilled to announce the expansion of the Pancreas View transcriptomic signatures to predict treatment response in metastatic pancreatic cancer using FNA biopsies. https://t.co/06opmwaFF3

11 Sep 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.